Gennao Bio
Gennao Bio is a biotech company in United States, founded in 2020. It has raised $55.0M across 2 rounds, most recently a $15.0M Venture Round in November 2022.
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2B
- Website
- gennaobio.com
- Total Funding
- $55.0M
- Last Round
- $15.0M Venture RoundNov 2022
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 3 investors for this company. The full record is or through the API.
About
Gennao Bio is a privately held genetic medicines company developing first-in-class targeted nucleic acid therapeutics utilizing a proprietary gene monoclonal antibody (GMAB) platform technology. GMAB is an adaptive technology that uses a novel, cell-penetrating antibody to non-covalently bind to and deliver therapeutic levels of a wide variety of nucleic acid payloads to select cells. This non-viral delivery platform is differentiated from traditional gene delivery systems as it can deliver multiple types of nucleic acids, allows for repeat dosing and employs well-established manufacturing processes. Gennao Bio is developing this delivery system with an initial focus on addressing significant unmet needs in oncology and rare monogenic skeletal muscle diseases.
Summary
It lists 1–10 employees. It has raised $55.0M in total across 2 rounds, most recently a $15.0M Venture Round in Nov 2022. Investors include Logos Capital, OrbiMed and Surveyor Capital.
Tech & App Stack
7 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Nov 2022
Sign up to see all 2 events
Funding: Series A through Venture Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/gennao-bio"><img src="https://indexed.vc/api/badge/company/gennao-bio" alt="Gennao Bio on Indexed.vc" width="260" height="76" /></a>